Pharmacology
DrugBankReceptor Profile
Receptor Actions
Receptor Binding
History & Culture
Kava originated in northern Vanuatu, where it was domesticated by farmers approximately 3,000 years ago through selective cultivation. The plant was subsequently spread eastward by the Austronesian Lapita culture into the rest of Polynesia, becoming endemic to Oceania while remaining absent from other Austronesian groups. The beverage reached Hawaii but could not establish itself in New Zealand due to the colder climate. In memory of the kava plants they brought with them and unsuccessfully attempted to cultivate, the Māori gave the name kawa-kawa to another Piperaceae species (M. excelsum). The Māori word "kawa" also came to mean "ceremonial protocol," reflecting the stylized consumption practices typical of Polynesian societies. Kava consumption is believed to be the reason betel nut chewing, otherwise ubiquitous among Austronesian peoples, was abandoned in Oceania.
Kava has been consumed in Pacific Island communities for over three millennia in religious, political, cultural, and social contexts, typically prepared as a beverage. Throughout the Pacific, the plant is treated with great respect and holds an important place in local cultures, though each society has developed its own distinct traditions alongside shared practices. In Fiji, formal yaqona ceremonies accompany significant social, political, and religious functions, usually involving a ritual presentation of bundled roots as a sevusevu (gift) followed by communal drinking. In precolonial Hawaii, the Aliʻi (kings) coveted the Moʻi variety for its strong cerebral effects, attributed to a predominant concentration of the kavalactone kavain. This sacred cultivar was restricted exclusively to royalty, with commoners forbidden from experiencing it on pain of death. In Vanuatu, the nakamal serves as the traditional central meeting place and cultural hub where kava consumption facilitates communal gathering, dialogue, and the exchange of knowledge across generations. In many Pacific communities, kava functions as a replacement for alcohol and is consumed throughout the day, particularly before spiritual rituals and social gatherings. Historically, it has been recognized as an entheogen of Pacific Island and Polynesian communities, playing an important role in various spiritual and ritualistic rites.
1778–present
Western interest in kava began with Captain Cook's voyages to the Pacific islands in 1778, though the beverage was initially regarded as inferior to alcohol. During the 18th and 19th centuries, Christian missionaries made efforts to prohibit kava drinking, which inadvertently led to changes in preparation methods. Historically, the beverage had been made exclusively from fresh kava root; in response to missionary restrictions, preparation from dried kava emerged as an alternative practice. In recent decades, facilitated largely by the internet, kava has become available to users worldwide and has been adopted by increasing numbers of people outside the Pacific region. Nakamals and kava bars now exist in many countries, where the beverage can be consumed in a social setting similar to traditional practices. As a major traditional producer, Vanuatu has introduced legislation focused on regulating the quality of its kava exports rather than restricting domestic availability.
Demographics
Gender Distribution
Age Distribution
Reports Over Time
Effect Analysis
Erowid + BluelightEffects aggregated from 194 experience reports (188 Erowid + 6 Bluelight)
Effect Sentiment Distribution
Confidence Distribution
Positive Effects 25
Adverse Effects 8
Dose-Response Correlation
How effect frequency changes across dose levels
View data table
| Effect | Heavy (n=26) |
|---|---|
| Euphoria | 46.2% |
| Sedation | 38.5% |
| Anxiety Suppression | 30.8% |
| Color Enhancement | 26.9% |
| Nausea | 26.9% |
| Visual Distortions | 23.1% |
| Stimulation | 23.1% |
| Music Enhancement | 23.1% |
| Focus Enhancement | 19.2% |
| Empathy | 19.2% |
| Confusion | 15.4% |
| Body High | 11.5% |
| Pain Relief | 11.5% |
| Tactile Enhancement | 11.5% |
| Auditory Effects | 7.7% |
Dose–Effect Mapping
Experience ReportsHow reported effects shift across dose tiers, based on 188 experience reports.
Limited tier coverage — most reports fall within the Heavy range. Effects at other dose levels may not be represented.
| Effect | Heavy (n=26) | |
|---|---|---|
| euphoria | ||
| sedation | ||
| anxiety suppression | ||
| color enhancement | ||
| nausea | ||
| visual distortions | ||
| stimulation | ||
| music enhancement | ||
| focus enhancement | ||
| empathy | ||
| confusion | ||
| body high | ||
| pain relief | ||
| tactile enhancement | ||
| auditory effects | ||
| muscle tension | ||
| headache | ||
| dissociation |
Dosage Distribution
Dose distribution from experience reports
Real-World Dose Distribution
62K DosesFrom 290 individual dose entries
Oral (n=84)
Common Combinations
Most co-occurring substances in experience reports
Form / Preparation
Most common forms and preparations reported
Body-Weight Dosing
Dose relative to body weight from reports with weight data
Redose Patterns
Redosing behavior across 168 reports
Legal Status
| Country | Status | Notes |
|---|---|---|
| Australia | Regulated | Governed by the National Code of Kava Management since June 2007. Commercial importation is prohibited except for medical or scientific purposes. Individuals aged 18 or older may bring up to 2 kg in accompanied baggage for personal use. |
| Brazil | Legal | Kava is sold in herb shops without specific regulatory controls. Recreational use is reportedly uncommon. |
| Canada | Restricted (commercial sale banned) | Health Canada issued a stop order in August 2002 prohibiting the sale of kava products for human consumption. All kava-containing products including beverages and supplements are banned from commercial sale. However, personal purchase and importation from foreign vendors is not illegal for Canadian citizens. |
| Ethiopia | Legal | Kava products are available for purchase without age restrictions. |
| France | Banned for sale | Kava supplements and products are prohibited from commercial sale. The raw plant Piper methysticum may reportedly still be available through herbalists. |
| Germany | Restricted | Following multiple reported cases of liver toxicity, including fatalities and transplants, regulations were tightened. Kava preparations are now required to be sold only in significantly diluted formulations. |
| Israel | Uncertain | Legal status remains unclear due to conflicting reports. Some sources indicate kava is legal to possess, import, and sell, while others suggest it may be prohibited. |
| Netherlands | Banned for sale | Kava-containing products have been prohibited from general sale since January 2003. |
| New Zealand | Legal | Kava supplements are widely available and sold at grocery stores without significant restriction. |
| Norway | Prescription only | While not specifically scheduled as a controlled substance, the national health council classifies kava as a prescription medication due to its psychoactive properties, restricting availability to pharmacies only. |
| Sweden | Banned for sale (import permitted) | Commercial sale of kava within Sweden is prohibited. Personal importation for individual use is permitted. |
| Switzerland | Restricted | Kavalactone-containing pharmaceutical products such as Laitan have been banned from sale in pharmacies. |
| United Kingdom | Restricted (medicinal products banned) | Under Statutory Instrument 2002 No.3170 (The Medicines for Human Use (Kava-kava) (Prohibition) Order 2002), selling, supplying, or importing medicinal products containing kava for human consumption is prohibited. Personal possession remains legal, and importation for non-consumption purposes is permitted. |
| United States | Unscheduled | Kava remains legal for sale, possession, and ingestion. While the FDA previously raised concerns regarding potential liver toxicity, these remarks have since been archived and no scheduling action was taken. The substance is widely available in health food stores as liquid extracts and capsules. |
| Vanuatu | Regulated (export quality) | As a major traditional producer, Vanuatu has enacted legislation focusing on regulating the quality of kava exports rather than restricting domestic availability. |
References
Data Sources
Cited References
- Chua et al. 2016: Kavain GABA-A Receptor Potentiation
- Drug Science: Kava
- Erowid: Kava Vault
- Li & Ramzan 2010: Ethanol and Kava Hepatotoxicity
- Ligresti et al. 2012: Yangonin CB1 Receptor Activity
- Magura et al. 1997: Kava Sodium Channel Inhibition
- Wikipedia: Kavalactone
- DrugBank Article: Liver toxicity of Kava